Objective: To identify the prognostic factors causing persistent storage symptoms following transurethral resection of the prostate in patients with benign prostatic enlargement (BPE). Methods: A total of 116 men with symptomatic BPE requiring surgery were enrolled in the study between January 2011 and December 2012. The patients underwent basic clinical evaluations including transrectal ultrasound, International Prostate Symptom Score and urodynamic study. After 6 months, International Prostate Symptom Score and uroflowmetry were rechecked. The definition of persistent storage symptoms was patients with storage scores >7 points. Logistic regression analysis and receiver operating characteristic analysis were conducted. Results: The 116 patients were divided into a persistent storage symptom-positive group (n = 33) and a storage symptom-negative group (n = 83). Multivariate analysis showed that the degrees of worse initial storage symptoms (odds ratio [OR] = 8.32), small bladder capacity (OR = 4.31), impaired detrusor contractility (OR = 2.96) and age (OR = 1.05) were consistently associated with persistent storage symptoms. Conclusions: This short-term study confirms the positive and consistent correlations between the baseline degree of worse initial storage symptoms, bladder capacity, detrusor contractility and age and the improvement in storage symptoms.

1.
Homma Y, Gotoh M, Yokoyama O, Masumori N, Kawauchi A, Yamanishi T, Ishizuka O, Seki N, Kamoto T, Nagai A, Ozono S; Japanese Urological Association: Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol 2011;18:741-756.
2.
Hakenberg OW, Pinnock CB, Marshall VR: Does evaluation with the International Prostate Symptom Score predict the outcome of transurethral resection of the prostate? J Urol 1997;158:94-99.
3.
Gormley EA, Griffiths DJ, McCracken PN, Harrison GM, McPhee MS: Effects of transurethral resection of the prostate on detrusor instability and urge incontinence in elderly males. Neurourol Urodyn 1993;12:445-453.
4.
Vesely S, Knutson T, Fall M, Damber JE, Dahlstrand C: Clinical diagnosis of bladder outlet obstruction in men with lower urinary tract symptoms: reliability of commonly measured parameters and the role of idiopathic detrusor overactivity. Neurourol Urodyn 2003;22:301-305.
5.
Peters TJ, Donovan JL, Kay HE, Abrams P, de la Rosette JJ, Porru D, Thüroff JW: The International Continence Society ‘Benign Prostatic Hyperplasia' Study: the bothersomeness of urinary symptoms. J Urol 1997;157:885-889.
6.
Abrams PH: The urodynamic changes following prostatectomy. Urol Int 1978;33:181-186.
7.
Homma Y, Yamaguchi O, Hayashi K; Neurogenic Bladder Society Committee: An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 2005;96:1314-1318.
8.
Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O: Symptom assessment tool for overactive bladder syndrome - overactive bladder symptom score. Urology 2006;68:318-323.
9.
Losco G, Mark S, Jowitt S: Transurethral prostate resection for urinary retention: does age affect outcome? ANZ J Surg 2013;83:243-245.
10.
Knutson T, Edlund C, Fall M, Dahlstrand C: BPH with coexisting overactive bladder dysfunction - an everyday urological dilemma. Neurourol Urodyn 2001;20:237-247.
11.
Diokno AC, Brown MB, Goldstein N, Herzog AR: Epidemiology of bladder emptying symptoms in elderly men. J Urol 1992;148:1817-1821.
12.
Oh MM, Choi H, Park MG, Kang SH, Cheon J, Bae JH, Moon du G, Kim JJ, Lee JG: Is there a correlation between the presence of idiopathic detrusor overactivity and the degree of bladder outlet obstruction? Urology 2011;77:167-170.
13.
Levin RM, Levin SS, Zhao Y, Buttyan R: Cellular and molecular aspects of bladder hypertrophy. Eur Urol 1997;32:15-21.
14.
Van Venrooij GE, Van Melick HH, Eckhardt MD, Boon TA: Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate. J Urol 2002;168:605-609.
15.
de Nunzio C, Franco G, Rocchegiani A, Iori F, Leonardo C, Laurenti C: The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol 2003;169:535-539.
16.
Tanaka Y, Masumori N, Itoh N, Furuya S, Ogura H, Tsukamoto T: Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity? Int J Urol 2006;13:1398-1404.
17.
Seki N, Takei M, Yamaguchi A, Naito S: Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargement. Neurourol Urodyn 2006;25:428-432.
18.
Porru D, Jallous H, Cavalli V, Sallusto F, Rovereto B: Prognostic value of a combination of IPSS, flow rate and residual urine volume compared to pressure-flow studies in the preoperative evaluation of symptomatic BPH. Eur Urol 2002;41:246-249.
19.
Machino R, Kakizaki H, Ameda K, Shibata T, Tanaka H, Matsuura S, Koyanagi T: Detrusor instability with equivocal obstruction: a predictor of unfavorable symptomatic outcomes after transurethral prostatectomy. Neurourol Urodyn 2002;21:444-449.
20.
Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P: The long term urodynamic follow-up of TURP: a study of the prevalence of detrusor instability. J Urol Suppl 1999;161:257.
21.
Han DH, Jeong YS, Choo MS, Lee KS: The efficacy of transurethral resection of the prostate in the patients with weak bladder contractility index. Urology 2008;71:657-661.
22.
Javlé P, Jenkins SA, West C, Parsons KF: Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy. J Urol 1996;156:1014-1018; discussion 1018-1019.
23.
Javlé P, Jenkins SA, Machin DG, Parsons KF: Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy. J Urol 1998;160:1713-1717.
24.
Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P: The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol 2005;174:1887-1891.
25.
Seki N, Yuki K, Takei M, Yamaguchi A, Naito S: Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Neurourol Urodyn 2009;28:197-201.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.